Drugs & TargetsFree FDA grants breakthrough designation for Avelumab in combination with Inlyta in RCC January 05, 2018Vol.44 No.01
Drugs & TargetsFree FDA grants orphan drug designation to Aptose Biosciences for CG’806 in AML January 05, 2018Vol.44 No.01
Drugs & TargetsFree FDA accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated NSCLC January 05, 2018Vol.44 No.01
Drugs & TargetsFree FDA grants priority review for Apalutamide in non-metastatic castration-resistant prostate cancer January 05, 2018Vol.44 No.01
Drugs & TargetsFree Janssen and Legend Biotech enter deal to develop CAR-T therapy January 05, 2018Vol.44 No.01
Clinical RoundupFree CAP publishes guideline to ensure accurate HPV testing in head and neck cancers January 05, 2018Vol.44 No.01
Clinical RoundupFree CAR-T therapy cancer study published in the New England Journal of Medicine January 05, 2018Vol.44 No.01
Clinical RoundupFree Cancer mortality in the U.S. continues decades-long drop January 05, 2018Vol.44 No.01
FreeTrials & Tribulations Cabozantinib in first-line treatment of metastatic renal cell carcinoma January 05, 2018Vol.44 No.01By Tian Zhang, Michael J. Morris, Darren R. Feldman, Toni K. Choueiri and Daniel J. George
